Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thrombocytosis | 1 | 2016 | 81 | 0.570 |
Why?
|
Polycythemia | 1 | 2016 | 126 | 0.540 |
Why?
|
Ribonuclease III | 3 | 2013 | 275 | 0.410 |
Why?
|
Aphasia | 1 | 2013 | 179 | 0.400 |
Why?
|
DEAD-box RNA Helicases | 3 | 2013 | 375 | 0.390 |
Why?
|
Carcinoma, Transitional Cell | 3 | 2024 | 808 | 0.370 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 5221 | 0.360 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2013 | 500 | 0.320 |
Why?
|
Lung Neoplasms | 4 | 2023 | 13102 | 0.280 |
Why?
|
MicroRNAs | 4 | 2013 | 3752 | 0.240 |
Why?
|
Mesenchymal Stem Cells | 2 | 2013 | 1632 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2942 | 0.210 |
Why?
|
Sarcoma | 1 | 2012 | 1897 | 0.190 |
Why?
|
Primary Health Care | 1 | 2016 | 4558 | 0.180 |
Why?
|
Cell Proliferation | 1 | 2012 | 10481 | 0.140 |
Why?
|
Hematologic Tests | 1 | 2016 | 240 | 0.130 |
Why?
|
Autoantibodies | 1 | 2024 | 2035 | 0.130 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2007 | 0.130 |
Why?
|
Urologic Neoplasms | 1 | 2019 | 318 | 0.130 |
Why?
|
RNA | 2 | 2022 | 2749 | 0.120 |
Why?
|
Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2013 | 3 | 0.120 |
Why?
|
Blotting, Northern | 2 | 2012 | 1581 | 0.110 |
Why?
|
Stroke | 1 | 2013 | 9981 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2022 | 2245 | 0.090 |
Why?
|
Multigene Family | 1 | 2011 | 1102 | 0.080 |
Why?
|
Tamoxifen | 1 | 2012 | 981 | 0.080 |
Why?
|
TRPV Cation Channels | 1 | 2009 | 236 | 0.080 |
Why?
|
Software | 1 | 2021 | 4443 | 0.070 |
Why?
|
Genomics | 1 | 2023 | 5720 | 0.070 |
Why?
|
Embryonic Stem Cells | 2 | 2011 | 1294 | 0.070 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2088 | 0.070 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.070 |
Why?
|
Cell Polarity | 1 | 2009 | 645 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4751 | 0.060 |
Why?
|
Blotting, Western | 1 | 2012 | 5179 | 0.060 |
Why?
|
Mechanotransduction, Cellular | 1 | 2009 | 541 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2012 | 1524 | 0.060 |
Why?
|
Cells, Cultured | 4 | 2012 | 19229 | 0.060 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2012 | 0.060 |
Why?
|
Melanoma | 1 | 2022 | 5510 | 0.060 |
Why?
|
Genome | 1 | 2011 | 1808 | 0.050 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 182 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2012 | 14557 | 0.050 |
Why?
|
Fibroblasts | 1 | 2013 | 4161 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2012 | 9438 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5974 | 0.050 |
Why?
|
Antigens, Neoplasm | 2 | 2024 | 1988 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12959 | 0.050 |
Why?
|
Humans | 14 | 2024 | 744343 | 0.050 |
Why?
|
Mice | 5 | 2023 | 81183 | 0.050 |
Why?
|
Disease Progression | 1 | 2016 | 13284 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9734 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 841 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 890 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 12072 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1038 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2009 | 3479 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 8428 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 29063 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20129 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 16689 | 0.030 |
Why?
|
Gene Deletion | 2 | 2013 | 2751 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 21827 | 0.030 |
Why?
|
Animals | 6 | 2023 | 168757 | 0.030 |
Why?
|
Caspase 2 | 1 | 2011 | 27 | 0.030 |
Why?
|
RNA Interference | 2 | 2011 | 2889 | 0.020 |
Why?
|
Cell Survival | 2 | 2011 | 5882 | 0.020 |
Why?
|
Pregnancy | 1 | 2013 | 29144 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3586 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2011 | 1085 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2013 | 809 | 0.020 |
Why?
|
Gamma Rays | 1 | 2011 | 320 | 0.020 |
Why?
|
Base Sequence | 2 | 2011 | 12797 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3597 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2011 | 513 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4479 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6895 | 0.020 |
Why?
|
Mutation | 2 | 2022 | 29786 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 692 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7880 | 0.020 |
Why?
|
Female | 4 | 2022 | 380194 | 0.020 |
Why?
|
Capillaries | 1 | 2009 | 773 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1157 | 0.020 |
Why?
|
Fibronectins | 1 | 2009 | 726 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
Aged | 3 | 2024 | 163280 | 0.020 |
Why?
|
Doxorubicin | 1 | 2011 | 2234 | 0.020 |
Why?
|
Adult | 2 | 2022 | 214055 | 0.020 |
Why?
|
Phylogeny | 1 | 2011 | 2803 | 0.010 |
Why?
|
Male | 4 | 2024 | 350118 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18029 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2009 | 1686 | 0.010 |
Why?
|
Cattle | 1 | 2009 | 3922 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2011 | 4740 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15076 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2009 | 3144 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2013 | 3617 | 0.010 |
Why?
|
DNA Damage | 1 | 2011 | 2432 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9386 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3772 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2011 | 3023 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3505 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40561 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2938 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15997 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 18111 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2022 | 57776 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5853 | 0.010 |
Why?
|
Young Adult | 1 | 2022 | 56430 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9727 | 0.010 |
Why?
|
Transcription Factors | 1 | 2011 | 12208 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 77449 | 0.010 |
Why?
|
Middle Aged | 1 | 2022 | 213383 | 0.000 |
Why?
|
Signal Transduction | 1 | 2011 | 23403 | 0.000 |
Why?
|
Concepts
(115)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_